SE327501B - - Google Patents

Info

Publication number
SE327501B
SE327501B SE12160/64A SE1216064A SE327501B SE 327501 B SE327501 B SE 327501B SE 12160/64 A SE12160/64 A SE 12160/64A SE 1216064 A SE1216064 A SE 1216064A SE 327501 B SE327501 B SE 327501B
Authority
SE
Sweden
Application number
SE12160/64A
Inventor
H Bickel
F Kradolfer
W Kump
I Furesz
G Gallo
P Sensi
Original Assignee
Ciba Geigy
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy, Lepetit Spa filed Critical Ciba Geigy
Publication of SE327501B publication Critical patent/SE327501B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE12160/64A 1963-10-11 1964-10-09 SE327501B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1254063A CH478139A (de) 1963-10-11 1963-10-11 Verfahren zur Herstellung neuer antibiotisch wirksamer Kondensationsprodukte von Rifamycin O
CH1004564A CH504457A (de) 1963-10-11 1964-07-31 Verfahren zur Herstellung neuer antibiotisch wirksamer Kondensationsprodukte von Rifamycin S
CH1179764 1964-09-10

Publications (1)

Publication Number Publication Date
SE327501B true SE327501B (is) 1970-08-24

Family

ID=27176360

Family Applications (2)

Application Number Title Priority Date Filing Date
SE12160/64A SE327501B (is) 1963-10-11 1964-10-09
SE17190/68A SE342458B (is) 1963-10-11 1968-12-16

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE17190/68A SE342458B (is) 1963-10-11 1968-12-16

Country Status (14)

Country Link
US (1) US3338888A (is)
AT (1) AT261805B (is)
BE (1) BE654209A (is)
BR (1) BR6463319D0 (is)
CH (2) CH478139A (is)
DE (1) DE1445634A1 (is)
ES (1) ES304831A1 (is)
FI (1) FI41029C (is)
FR (4) FR4134M (is)
GB (1) GB1081757A (is)
IL (1) IL22215A (is)
NL (2) NL6411794A (is)
OA (1) OA01187A (is)
SE (2) SE327501B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH536851A (de) * 1966-10-25 1973-05-15 Ciba Geigy Ag Verfahren zur Herstellung neuer antibiotisch wirksamer Verbindungen der Rifamycinreihen
GB1165179A (en) * 1966-10-25 1969-09-24 Lepetit Spa Derivatives of Rifamycin SV
GB1159267A (en) * 1966-11-03 1969-07-23 Lepetit Spa Rifamycin Derivatives
IT1056271B (it) * 1975-05-20 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
US4690919A (en) * 1984-01-04 1987-09-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JPS63183587A (ja) * 1985-02-05 1988-07-28 Kanegafuchi Chem Ind Co Ltd ベンゾキサジノリフアマイシン誘導体
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
JP2544375B2 (ja) * 1986-07-14 1996-10-16 鐘淵化学工業株式会社 アルキル置換ベンゾキサジノリフアマイシン誘導体
DE68924722T2 (de) * 1988-03-18 1996-04-18 Kanegafuchi Chemical Ind Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
CA1304363C (en) * 1988-11-01 1992-06-30 Takehiko Yamane 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
EP0787494B1 (en) * 1995-09-01 2004-06-09 Kaneka Corporation Use of rifamycin derivatives for the manufacture of a medicament for the treatment of diseases caused by infections of helicobacter pylori
WO2003045319A2 (en) * 2001-11-21 2003-06-05 Activbiotics, Inc. Targeted therapeutics and uses thereof
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
AU2004268531A1 (en) * 2003-08-22 2005-03-10 Activbiotics, Inc. Rifamycin analogs and uses thereof
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
AU2004298983A1 (en) * 2003-12-10 2005-06-30 Activbiotics, Inc. Rifamycin analogs and uses thereof
AU2004308399A1 (en) * 2003-12-23 2005-07-14 Activbiotics, Inc. Rifamycin analogs and uses thereof

Also Published As

Publication number Publication date
FR4122M (is) 1966-04-25
FR4133M (is) 1966-05-02
FR4152M (is) 1966-05-09
CH478139A (de) 1969-09-15
NL6411794A (is) 1965-04-12
DE1445634A1 (de) 1968-12-05
GB1081757A (en) 1967-08-31
FI41029C (fi) 1969-08-11
FI41029B (is) 1969-04-30
US3338888A (en) 1967-08-29
BE654209A (is) 1965-04-09
BR6463319D0 (pt) 1973-07-17
ES304831A1 (es) 1965-04-01
CH504457A (de) 1971-03-15
OA01187A (fr) 1969-01-25
NL130099C (is)
AT261805B (de) 1968-05-10
IL22215A (en) 1968-06-20
SE342458B (is) 1972-02-07
FR4134M (is) 1966-05-02

Similar Documents

Publication Publication Date Title
AR142945A1 (is)
FI41029B (is)
AT260747B (is)
FR3946M (is)
BE582314A (is)
BE614220A (is)
BE626590A (is)
BE626803A (is)
BE626826A (is)
BE31062A (is)
BE462764A (is)
BE465565A (is)
BE507458A (is)
BE533484A (is)
BE547422A (is)
BE571209A (is)
BE627141A (is)
BE603935A (is)
BE608372A (is)
BE612803A (is)
BE627083A (is)
BE616247A (is)
BE616830A (is)
BE616967A (is)
BE619061A (is)